Galapagos NV (GLPG)
29.42
-0.34
(-1.14%)
USD |
NASDAQ |
Apr 02, 16:00
29.50
+0.08
(+0.27%)
After-Hours: 20:00
Galapagos Shareholders Equity (Quarterly) : 3.800B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 22.70B |
| UCB SA | -- |
| Celyad Oncology SA | -- |
| Fagron NV | -- |
| AgomAb Therapeutics NV | 194.76M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.001B |
| Total Liabilities (Quarterly) | 200.42M |
| Debt to Equity Ratio | 0.0021 |
| Current Ratio | 20.11 |
| Net Debt Paydown Yield | 0.04% |